News & Events about Repare Therapeutics Inc.
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Repare Therapeutics Inc. (Repare or the Company) (NASDAQ: RPTX). Investors who purchased Repare securities are encouraged to obtain additional information and assist the...
Morgan Stanley cut shares of Repare Therapeutics (NASDAQ:RPTX Get Rating) from an overweight rating to an equal weight rating in a report released on Friday, MarketBeat reports. The firm currently has $15.00 price objective on the stock, down from their previous price objective of $28.00. A number ...
Repare Therapeutics Inc. (Repare or the Company) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced that the Company has received an approximately $1.5 million (200 million) research service payment from Ono Pharmaceutical Co., Ltd. (Ono). The payment reflects...
Market News Video
4 months ago
In trading on Tuesday, shares of Repare Therapeutics Inc (RPTX) crossed above their 200 day moving average of 13.60, changing hands as high as 13.69 per share. Repare Therapeutics Inc shares are currently trading up about 7.2% on the day...
Ticker Report
8 months ago
Zacks Investment Research upgraded shares of Repare Therapeutics (NASDAQ:RPTX Get Rating) from a sell rating to a hold rating in a research note released on Thursday, Zacks.com reports. According to Zacks, Repare Therapeutics Inc. is an oncology company. It utilizes genome-wide, ...